Cardio Diagnostics Holdings, Inc. announced the results of its annual stockholder meeting held on September 18, 2026. Shareholders approved all proposals, including a key measure authorizing the company to issue shares equal to 20% or more of its outstanding common stock in future non-public offerings.
Key Details
- Share Issuance Proposal: Shareholders approved the potential future issuance of common stock and/or convertible securities equal to 20% or more of the outstanding shares, as required by Nasdaq Listing Rule 5635(d).
- Director Elections: All seven director nominees were elected to the Board of Directors to serve for the ensuing year.
- Auditor Ratification: The appointment of Prager Metis CPA’s LLC as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.